Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02925312 · ClinicalTrials.gov registry record · NA
MedStar Health Type 2 Diabetes Pathway to Control
A NA study, sponsored by Medstar Health Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 419
- Enrollment target
NCT02925312: Completed NA study, sponsored by Medstar Health Research Institute.
NCT02925312 is a NA study that has completed, run by Medstar Health Research Institute. The registered enrollment target is 419 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02925312, a NA study, has completed, sponsored by Medstar Health Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 419 participants
- Enrollment target
Study Summary
A Diabetes Institute (MDI), in partnership with key stakeholders-including Primary Care Providers- in a northeastern US regional, mixed-payer healthcare system), seeks to implement an evidence-based, technology-enabled, innovative, and integrated diabetes care management pathway (Boot Camp) for adult patients with uncontrolled type 2 diabetes (A1C\>/=9%) which will demonstrate improvement in diabetes clinical and health resources utilization outcomes.
Primary Outcome
Comparison of the percentage change in A1C from baseline to 3 months between the intervention and the control group
Interventions
- OTHER Diabetes Pathway
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 419 participants |
| Start Date | 2014-11 |
| Est. Completion | 2016-12-31 |
| Phase | NA |
What the finished NCT02925312 record still lists
NCT02925312 is an interventional study that assigns participants to a tested intervention. The registered 419 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower).
The record links to 0 conditions, and to 1 intervention - of which Diabetes Pathway is the first listed.
NCT02925312 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02925312 about?
NCT02925312 is a clinical study titled "MedStar Health Type 2 Diabetes Pathway to Control". A Diabetes Institute (MDI), in partnership with key stakeholders-including Primary Care Providers- in a northeastern US regional, mixed-payer healthcare system), seeks to implement an evidence-based, technology-enabled, innovative, and integrated diabetes care management pathway (Boot Camp) for adul...
What is the current status of trial NCT02925312?
This trial is currently completed. It is a NA study. The enrollment target is 419 participants. The study started on 2014-11. Estimated completion is 2016-12-31.
What interventions are being tested in trial NCT02925312?
The interventions under investigation include: Diabetes Pathway (OTHER).
Who is sponsoring clinical trial NCT02925312?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02925312's enrollment target sits among peer trials
419 240th of 2000 higher than 1,761 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05579639 · 419 participants · Phase 2
Xylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant
- NCT01790152 · 420 participants
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- NCT02701244 · 420 participants
A Registry Study of Breast Microseed Treatment
- NCT02966665 · 420 participants · Phase 1
: Vascular Function in Health and Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia